These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 4054327)

  • 1. Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine.
    Boulanger CM; Mashchak CA; Chang RJ
    Fertil Steril; 1985 Oct; 44(4):532-5. PubMed ID: 4054327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine.
    Nillius SJ; Bergh T; Lundberg PO; Stahle J; Wide L
    Fertil Steril; 1978 Dec; 30(6):710-2. PubMed ID: 729834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term medical therapy and follow-up of pediatric-adolescent patients with prolactin-secreting macroadenomas.
    Blackwell RE; Younger JB
    Fertil Steril; 1986 May; 45(5):713-6. PubMed ID: 3699173
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
    Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A
    Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amenorrhea, galactorrhea, and hyperprolactinemia.
    Magyar DM
    J Am Osteopath Assoc; 1985 Jun; 85(6):375-80. PubMed ID: 3905728
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of galactorrhea-amenorrhea.
    De Leon FD
    Am Fam Physician; 1985 Dec; 32(6):121-4. PubMed ID: 4072865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of women with amenorrhea-galactorrhea treated with bromocriptine.
    Tartagni M; Nicastri PL; Diaferia A; Di Gesù I; Loizzi P
    Clin Exp Obstet Gynecol; 1995; 22(4):301-6. PubMed ID: 8777784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of pregnancy and lactation on pituitary prolactin-secreting tumours.
    Zárate A; Canales ES; Alger M; Forsbach G
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):407-12. PubMed ID: 517046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinemia. Long-term effects of bromocriptine.
    Johnston DG; Prescott RW; Kendall-Taylor P; Hall K; Crombie AL; Hall R; McGregor A; Watson MJ; Cook DB
    Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination of prolactinoma from hyperprolactinemic non-functioning adenoma.
    Hong JW; Lee MK; Kim SH; Lee EJ
    Endocrine; 2010 Feb; 37(1):140-7. PubMed ID: 20963563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
    Goodman LA; Chang RJ
    Obstet Gynecol; 1984 Sep; 64(3 Suppl):2S-7S. PubMed ID: 6433250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.
    Gheri RG; Boddi W; Ammannati F; Olivotto J; Nozzoli C; Franchi A; Bordi L; Luisi ML; Mennonna P
    J Endocrinol Invest; 1997 Apr; 20(4):240-4. PubMed ID: 9211134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of 246 hyperprolactinemic patients.
    Touraine P; Plu-Bureau G; Beji C; Mauvais-Jarvis P; Kuttenn F
    Acta Obstet Gynecol Scand; 2001 Feb; 80(2):162-8. PubMed ID: 11167213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin secreting pituitary adenoma: a review and study of their implications for fertility in women.
    Fode NC; Laws ER; Abboud CF; Randall RV; Kempers RD
    J Neurosurg Nurs; 1980 Dec; 12(4):210-3. PubMed ID: 6906361
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection, evaluation, and treatment of pituitary microadenomas in patients with galactorrhea and amenorrhea.
    Chang RJ; Keye WR; Young JR; Wilson CB; Jaffe RB
    Am J Obstet Gynecol; 1977 Jun; 128(4):356-63. PubMed ID: 559413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromocriptine treatment of women with suspected pituitary prolactin-secreting microadenomas.
    Archer DF; Lattanzi DR; Moore EE; Harger JH; Herbert DL
    Am J Obstet Gynecol; 1982 Jul; 143(6):620-5. PubMed ID: 7201244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bromocriptine on patients with hyperprolactinemia and amenorrhea.
    Meduri M; Deodato M; Bramanti P; Volpe A; Grasso A; Di Perri R
    Acta Neurol (Napoli); 1980 Feb; 2(1):15-22. PubMed ID: 7190350
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperprolactinemia in nonpregnant women due to pituitary tumors.
    Tolstoi LG
    Life Sci; 1986 Jun; 38(22):1981-9. PubMed ID: 3012232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.